
Engineering cancer-fighting CAR-T cells directly inside the patient's body
Key Takeaway:
New in vivo CAR-T therapy for multiple myeloma promises faster, more efficient treatment options, potentially overcoming current therapy limitations, but is still in the research phase.
What this means for you
This early research on CAR-T therapy for multiple myeloma shows promise but is years away from being available. Continue with your current treatment plan and consult your doctor for personalized advice.
Citation:
Nature Medicine - AI Section, 2026. DOI: s41591-026-04296-8 Read article β






